Valeritas Holdings Inc (NASDAQ: VLRX) is climbing in the market today, and for good reason. The company announced positive clinical outcomes of its V-Go device, exciting investors and pushing the stock on a run up. Today, we’ll talk about: The data; what we’re seeing from VLRX stock as a result; and what we’ll be watching … Read more
Valeritas Holdings Inc (NASDAQ: VLRX) saw tremendous gains on Monday, June 25th, closing the day up 13.38% and enjoying intra-day highs of more than 30%. The gains proved to be the result of data released by the company at the American Diabetes Association Meeting in Orlando, Florida. The data, provided by way of 3 poster presentations, … Read more
Valeritas Holdings Inc (NASDAQ: VLRX) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The comapny announced positive results from a key clinical study. Of course, the positive results excited investors, sending the stock screaming for the top. Today, we’ll talk about: The study; what we’re seeing from … Read more
Any company in the biotechnology space has a pretty similar goal. Ultimately, these companies aim to create drugs and treatment devices that won’t only make it to the market, but will change the lives of patients and generate profits in the process. For Valeritas Holdings Inc (NASDAQ: VLRX), the medical product of focus is known as … Read more
Valeritas Holdings Inc (NASDAQ: VLRX) is skyrocketing in the market today with the stock doubling in value so far. The gains are the result of news that the company has entered into a distribution agreement surrounding it’s V-Go® Wearable Insulin Delivery device. Of course, the agreement means expanded sales will be expected, leading to excitement … Read more